Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.
- Published In:
- Viruses, 11(8) (2019)
- Authors:
- Pu, Jing, Wang, Qian(6), Xu, Wei(2), Lu, Lu, Jiang, Shibo
- Database ID:
- RPEP-04430
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04430APA
Pu, Jing; Wang, Qian; Xu, Wei; Lu, Lu; Jiang, Shibo. (2019). Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.. Viruses, 11(8). https://doi.org/10.3390/v11080705
MLA
Pu, Jing, et al. "Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.." Viruses, 2019. https://doi.org/10.3390/v11080705
RethinkPeptides
RethinkPeptides Research Database. "Development of Protein- and Peptide-Based HIV Entry Inhibito..." RPEP-04430. Retrieved from https://rethinkpeptides.com/research/pu-2019-development-of-protein-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.